De-nest and present filled glass vials/syringes for aseptic inspection
In aseptic fill-finish of injectable biologics, filled primary containers (thin-walled glass vials and prefilled glass syringes) must be removed from nests/trays, oriented, and presented for visual/automated inspection and downstream handling within the sterile zone. The containers are fragile, lightweight, slippery when handled in gloves/isolators, and vary subtly in geometry, while being filled with high-value liquid or lyophilized product. The task sits between fill/stoppering and labeling/packaging and is throughput-critical but quality-sensitive. The difficulty is grasping fragile glass with enough force to control it but not enough to chip or crack it, in an environment where any glass breakage is a sterility and contamination event. Vision can verify position but cannot sense incipient glass-on-glass or glass-on-gripper contact stress. We identified this through our own research; we have not confirmed the specifics with the customer directly. This page is our researched read — a starting point for that conversation.
What the task is
RESEARCHED · our reconstructionIn aseptic fill-finish of injectable biologics, filled primary containers (thin-walled glass vials and prefilled glass syringes) must be removed from nests/trays, oriented, and presented for visual/automated inspection and downstream handling within the sterile zone. The containers are fragile, lightweight, slippery when handled in gloves/isolators, and vary subtly in geometry, while being filled with high-value liquid or lyophilized product. The task sits between fill/stoppering and labeling/packaging and is throughput-critical but quality-sensitive. The difficulty is grasping fragile glass with enough force to control it but not enough to chip or crack it, in an environment where any glass breakage is a sterility and contamination event. Vision can verify position but cannot sense incipient glass-on-glass or glass-on-gripper contact stress.
Is this the actual task and sequence? What are the real tolerances, cycle rate, and reject criteria, and which steps are today's manual bottleneck? Answering these is what turns this from a researched signal into a validated use case.